The causes of focal onset seizures can include epilepsy, stroke, or low blood sugar. Other times, the causes are unknown. Medication can help prevent focal seizures. The human brain works by sending ...
If your child has a seizure, it's natural to have plenty of concerns about what exactly happened, why, and what comes next. There are treatments that can help, but a lot depends on the cause of the ...
The International League Against Epilepsy (ILAE) has revised its classification of seizure types to improve nomenclature, add new seizure types, and give clinicians the ability to classify seizures ...
Focal or partial seizures begin in only one part of the brain. A person may experience muscle contractions, unusual sensations, and other symptoms. Possible causes range from epilepsy to dehydration.
Please provide your email address to receive an email when new articles are posted on . Patients with focal nonmotor seizures experienced a delay from first seizure to diagnosis that was 10 times ...
“At present, there is insufficient evidence to inform clinical practice regarding clobazam monotherapy in focal or generalized seizures,” concluded the authors, adding “There is a definite need for ...
Most newly diagnosed patients with focal epilepsy continued to have seizures for a year or more after starting antiseizure medications (ASMs), results from the latest Human Epilepsy Project (HEP) ...
In a first-in-humans pilot study, researchers have identified a sentinel area of the brain that may give an early warning before clinical seizure manifestations from focal epilepsy appear. They have ...
Los Angeles — Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications (ASMs), new research suggested. This is sobering information to pass ...
Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...
Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results